Who Owns Lianhe Chemical Technology Co. Company?

Lianhe Chemical Technology Co. Bundle

Get Bundle
Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10

TOTAL:

Who owns Lianhe Chemical Technology Co.?

Understanding a company's ownership is key to grasping its direction and influence. Major events like IPOs or acquisitions can significantly alter control and long-term vision. Lianhe Chemical Technology Co., established in 2003, is a global chemical manufacturer with roots tracing back to 1985.

Who Owns Lianhe Chemical Technology Co. Company?

As of August 4, 2025, Lianhe Chemical Technology Co., Ltd. holds a market capitalization of approximately $1.4 billion. The company, traded on the Shenzhen Stock Exchange, employs 5,403 people and reported $794 million in revenue for the twelve months ending March 31, 2025. Its market position highlights the importance of examining its shareholder base to understand the forces guiding its path.

The ownership structure of Lianhe Chemical Technology Co., Ltd. is primarily shaped by its founding family and significant institutional investors. Zhi Hua Wang, the founder, and his family maintain a substantial stake, influencing strategic decisions. Major institutional shareholders, including various investment funds and asset management firms, also play a crucial role in the company's governance and future direction. These entities collectively hold a significant portion of the company's shares, impacting its operational strategies and long-term growth plans, including its production of key intermediates for products like Lianhe Chemical Technology Co. PESTEL Analysis.

Who Founded Lianhe Chemical Technology Co.?

The foundation of Lianhe Chemical Technology Co., Ltd. traces back to 1985 with the establishment of the broader Lianhetech group by Zhi Hua Wang. While the precise initial ownership distribution among founders is not publicly detailed, Zhi Hua Wang is recognized as the principal founder, underscoring his pivotal role in the company's inception. The collective ambition of the founding team, spearheaded by Wang, was to emerge as a premier provider of chemistry and technology solutions across key global sectors.

Icon

Founder's Vision

The founding vision focused on becoming a leading solution and service provider in chemistry and technology.

Icon

Key Market Sectors

Targeted critical global markets including crop protection, pharmaceuticals, and performance chemicals.

Icon

Early Backing

Specific early backers or angel investors are not publicly identified, typical for early-stage private companies.

Icon

Consolidated Control

The emergence of 'Lianhe Holdings Ltd.' with a 40.21% ownership stake suggests consolidation of founding control.

Icon

Founding Agreements

No public information exists regarding early ownership disputes, buyouts, or specific shareholder agreements.

Icon

R&D Focus

The founding team's long-term vision emphasized innovation and sustainable chemical solutions, solidified by 2010.

The ownership history of Lianhe Chemical Technology Co., Ltd. indicates a foundational structure where the initial stakeholders, likely including founder Zhi Hua Wang, eventually consolidated their influence through 'Lianhe Holdings Ltd.'. This entity holds a significant 40.21% stake, pointing towards a concentrated ownership model established early in the company's development. The absence of publicly documented early ownership disputes or buyouts suggests a relatively stable transition of control from the inception of the Lianhetech group in 1985. The company's strategic direction, as outlined by its founding team, consistently prioritized research and development, a commitment that was firmly established by 2010, reflecting a long-term perspective on innovation and market leadership. Understanding this early ownership structure is key to grasping the company's trajectory and its approach to market challenges, as further explored in their Marketing Strategy of Lianhe Chemical Technology Co..

Icon

Early Ownership Dynamics

The initial phase of Lianhe Chemical Technology Co., Ltd. was shaped by the vision of its founder, Zhi Hua Wang, and the broader Lianhetech group established in 1985.

  • Zhi Hua Wang is identified as the primary founder.
  • Specific initial equity splits are not publicly disclosed.
  • 'Lianhe Holdings Ltd.' emerged as a major shareholder with 40.21% ownership.
  • No public records detail early ownership disputes or buy-sell agreements.

Lianhe Chemical Technology Co. SWOT Analysis

  • Complete SWOT Breakdown
  • Fully Customizable
  • Editable in Excel & Word
  • Professional Formatting
  • Investor-Ready Format
Get Related Template

How Has Lianhe Chemical Technology Co.’s Ownership Changed Over Time?

Lianhe Chemical Technology Co., Ltd. became a publicly traded entity on the Shenzhen Stock Exchange in 2015, a move that significantly diversified its ownership base. This initial public offering, which raised approximately 900 million RMB, marked a new era for the company, allowing for broader participation from institutional and individual investors and facilitating capital for future growth and research endeavors.

Stakeholder Group Ownership Percentage
Lianhe Holdings Ltd. 40.21%
China National Chemical Corporation 10.78%
Other Institutional Investors 27.94%
Public Shareholders 21.07%

The ownership structure of Lianhe Chemical Technology Co., Ltd. reflects its evolution into a publicly listed entity. As of October 2023, with a market capitalization of approximately RMB 21.89 billion, the company's major shareholders include Lianhe Holdings Ltd., holding a significant 40.21% stake, indicating continued control by the founding or primary group. China National Chemical Corporation is another key stakeholder with 10.78% ownership. The remaining shares are distributed among other institutional investors, who collectively own 27.94%, and public shareholders, who account for 21.07%. This diverse ownership landscape includes prominent fund management companies such as China Merchants Fund Management Co., Ltd., Lion Fund Management Co., Ltd., Gfund Management Co., Ltd., Fullgoal Fund Management Co., Ltd., Guotai Asset Management Co., Ltd., Founder Fubon Fund Management Co., Ltd., Huatai-PineBridge Fund Management Co., Ltd., and Tian Hong Asset Management Co., Ltd. These holdings underscore the company's integration into the broader capital markets and its strategic direction towards sustained profitability and global expansion, aligning with insights into its Revenue Streams & Business Model of Lianhe Chemical Technology Co.

Icon

Key Stakeholders in Lianhe Chemical Technology

Understanding who owns Lianhe Chemical Technology is crucial for assessing its strategic direction and corporate governance.

  • Lianhe Holdings Ltd. is the largest shareholder, maintaining significant influence.
  • China National Chemical Corporation holds a notable minority stake.
  • A substantial portion of ownership is held by various institutional investors.
  • Public shareholders represent a considerable segment of the company's ownership.

Lianhe Chemical Technology Co. PESTLE Analysis

  • Covers All 6 PESTLE Categories
  • No Research Needed – Save Hours of Work
  • Built by Experts, Trusted by Consultants
  • Instant Download, Ready to Use
  • 100% Editable, Fully Customizable
Get Related Template

Who Sits on Lianhe Chemical Technology Co.’s Board?

The board of directors at Lianhe Chemical Technology Co., Ltd. is composed of individuals representing significant shareholder interests, company management, and independent oversight. This structure aims to balance operational expertise with strategic guidance and accountability.

Position Name Role
Chairwoman and President Maggie Wang Leads the company's overall strategy and operations.
Vice Chairman Yinsheng Peng Supports the Chairwoman in strategic leadership.
Member of the Board of Directors, Senior Vice President Business Unit Performance Chemicals John He Oversees the performance chemicals division.
Member of the Board of Directors, Senior Vice President Business Unit Crop Protection Robin Fan Manages the crop protection business unit.
Secretary of the Board, Senior Vice President Tony Chen Handles board administration and senior management responsibilities.
Finance Director Matthew Xue Manages the company's financial operations.
Independent Director Jian Kai Jin Provides independent judgment and oversight.
Independent Director Li Wang Offers an independent perspective on board matters.
Independent Director Wei Cheng Zhou Contributes independent expertise to the board.
Chairman Ping Wang Presides over board meetings.
Chairman-Supervisory Board Xiao Hui Wang Leads the supervisory board.

Lianhe Chemical Technology Co., Ltd. operates with a standard one-share-one-vote system, typical for entities listed on the Shenzhen Stock Exchange. The company's ownership structure indicates that Lianhe Holdings Ltd. is a significant stakeholder, holding 40.21% of the company's shares. This substantial ownership suggests that Lianhe Holdings Ltd., which is understood to be connected to the founder Zhi Hua Wang and his family, wields considerable voting power. This influence is critical in corporate decision-making, including the selection of board members and the overall strategic direction of the company. The company's commitment to ethical practices and transparent corporate governance is a key aspect of its operations, aligning with its Mission, Vision & Core Values of Lianhe Chemical Technology Co.

Icon

Understanding Voting Power

The distribution of voting power is central to corporate control. Understanding who holds the majority of votes is key to assessing Lianhe Chemical Technology ownership.

  • Lianhe Holdings Ltd. holds 40.21% of the company's shares.
  • This stake implies significant influence over corporate decisions.
  • The company follows a one-share-one-vote structure.
  • Independent directors ensure diverse perspectives on the board.

Lianhe Chemical Technology Co. Business Model Canvas

  • Complete 9-Block Business Model Canvas
  • Effortlessly Communicate Your Business Strategy
  • Investor-Ready BMC Format
  • 100% Editable and Customizable
  • Clear and Structured Layout
Get Related Template

What Recent Changes Have Shaped Lianhe Chemical Technology Co.’s Ownership Landscape?

In recent years, Lianhe Chemical Technology Co., Ltd. has navigated a dynamic landscape, marked by strategic investments and shifts in its financial performance, influencing its ownership trends.

Development Date Details
Equity Buyback Program March 1, 2025 (Closed) 11,459,900 shares repurchased, representing 1.26% of shares, for CNY 80 million.
International Facility Investment November 2023 Up to USD200 million planned for a new facility in Malaysia through its Singapore unit.
Subsidiary Rebranding 2024 Lianhe Chemical Technology (Taizhou) Co., Ltd. rebranded as Lianhe Aigen Pharma Co., Ltd. after a share reform.
2024 Final Cash Dividend June 9, 2025 (Approved) CNY 0.20000000 per 10 shares.

The company's strategic maneuvers, including a significant international expansion and internal restructuring, are occurring against a backdrop of financial challenges. In 2023, revenue saw a decline of 18.10% year-over-year, with net profit dropping by 166.76%. This downward trend persisted into the first half of 2024, with revenue and net profit decreasing by 18.75% and 42.43% respectively, largely attributed to reduced order volumes. These financial results, coupled with strategic initiatives like the Growth Strategy of Lianhe Chemical Technology Co., are indicative of the company's efforts to adapt to evolving market conditions and strengthen its global presence, mirroring broader industry trends towards increased institutional ownership and consolidation within the chemical sector.

Icon Share Buyback Impact

The recent share buyback program, involving 1.26% of shares for CNY 80 million, is a move to enhance shareholder value.

Icon Global Expansion Strategy

An investment of up to USD200 million in Malaysia signals a commitment to expanding global production capabilities.

Icon Financial Performance Snapshot

Revenue and net profit experienced significant declines in 2023 and the first half of 2024 due to decreased orders.

Icon Internal Restructuring Focus

The rebranding of a subsidiary to Lianhe Aigen Pharma Co., Ltd. indicates internal specialization and strategic realignment.

Lianhe Chemical Technology Co. Porter's Five Forces Analysis

  • Covers All 5 Competitive Forces in Detail
  • Structured for Consultants, Students, and Founders
  • 100% Editable in Microsoft Word & Excel
  • Instant Digital Download – Use Immediately
  • Compatible with Mac & PC – Fully Unlocked
Get Related Template

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.